Company Overview

Network Immunology Inc. is a privately held biotechnology company developing novel immuno-therapies based on immune network theory.


Interview on Organ Transplantation, Harpreet Singh Show

CEO George Hoffman discusses Network Immunology's latest research breakthrough in organ transplantation. ..

Network Immunology Releases Breakthrough Data from Organ Transplantation Study

Toronto, ON: Network Immunology has received breakthrough data for its platform Co-selection Technology™ that has potential applications to transplantation, autoimmunity and other degenerati..

Network Immunology Completes Private Equity Financing

Vancouver, BC: Network Immunology has completed a financing in partnership with one of the largest wealth management firms in Canada. “We are delighted with this development, as it is a majo..

Corporate Updates

Captcha Image